PYGM Antikörper (C-Term)
Kurzübersicht für PYGM Antikörper (C-Term) (ABIN5531905)
Target
Alle PYGM Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 698-727, C-Term
-
Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
-
Immunogen
- This PYGM antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 698-727 amino acids from the C-terminal region of human PYGM.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 2 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- PYGM (Phosphorylase, Glycogen, Muscle (PYGM))
-
Andere Bezeichnung
- PYGM
-
Hintergrund
- PYGM catalyzes and regulates the breakdown of glycogen to glucose-1-phosphate. Defects in PYGM are the cause of glycogen storage disease type 5 (GSD5), also known as McArdle disease. GSD5 is a metabolic disorder resulting in myopathy characterized by exercise intolerance, cramps, muscle weakness and recurrent myoglobinuria.
-
Molekulargewicht
- 97 kDa
-
Gen-ID
- 5837
-
UniProt
- P11217
-
Pathways
- Cellular Glucan Metabolic Process
Target
-